a.palacios
Submits third-party assay reports on material purchased directly. Based in Dhaka.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.10%
n=8
Suppliers covered
5
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042116 | PT-141 (Bremelanotide) | TFC | TFC-2512-M8211 | Medutest | 2026-Q2 | 99.02 | 7.26 | 103.6 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041714 | Exenatide | QSC | QSC-2602-P9435 | PeptideMeter | 2026-Q2 | 98.45 | 5.10 | 103.4 | Supplier-supplied | 0 | PASS |
| AX-2026-042011 | Epitalon | TFC | TFC-2508-W5644 | Medutest | 2026-Q1 | 99.00 | 6.44 | 99.6 | Supplier-supplied | 0 | FAIL |
| AX-2025-020194 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2507-S1153 | Janoshik | 2025-Q3 | 99.93 | 5.30 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020259 | BPC-157 | GGPeps | GGPE-2502-U2458 | Kestrel | 2025-Q3 | 99.93 | 4.31 | 96.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021241 | L-Glutathione (reduced) | BCH | BCH-2508-X6429 | Janoshik | 2025-Q3 | 98.01 | 6.65 | 104.9 | Supplier-supplied | 0 | FAIL |
| AX-2024-004908 | Tirzepatide | ERP | ERP-2406-E6999 | Kestrel | 2024-Q3 | 99.19 | 4.74 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004441 | Afamelanotide | QSC | QSC-2407-F9884 | VendorInvestigate | 2024-Q3 | 99.55 | 3.17 | — | Buyer-sourced | 0 | PASS |